AHAnne N. Heirman

Anne N. Heirman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anne N. Heirman has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Lisette van der Molen

    Department of Head‐and‐Neck Oncology and Surgery Netherlands Cancer Institute – Antoni van Leeuwenhoek Amsterdam The Netherlands

    4 shared publications
  • Michiel Wilhelmus Maria van Den Brekel

    Department of Head and Neck Oncology and Surgery The Netherlands Cancer Institute Amsterdam The Netherlands

    4 shared publications
  • Richard Dirven

    Department of Head‐and‐Neck Oncology and Surgery Netherlands Cancer Institute – Antoni van Leeuwenhoek Amsterdam The Netherlands

    4 shared publications
  • Frank Hoebers

    Department of Radiation Oncology (Maastro) GROW School for Oncology and Reproduction, Maastricht University Medical Centre Maastricht The Netherlands

    2 shared publications
  • Gyorgy B. Halmos

    Department of Otolaryngology/Head and Neck Surgery University of Groningen, University Medical Center Groningen Groningen The Netherlands

    2 shared publications
  • Gyorgy Bela Halmos

    University Medical Center Groningen 4 Department of Otorhinolaryngology – Head and Neck Surgery Groningen, the Netherlands

    2 shared publications

Latest Publications

  • Open Access

    Are patient goals discussed during treatment decision-making in patients with head and neck cancer? A qualitative content analysis of consultations

    by Antje Lena Timmer, Anne N. Heirman, Song L.L. Duimel, Sebastiaan A.H.J. de Visscher, Michiel W.M. van Den Brekel, Gyorgy B. Halmos, Suzanne Festen

  • Open Access

    Exploring the state of shared decision-making in head and neck oncology: Assessing treatment communication

    by Anne N. Heirman, Song L.L. Duimel, Roosmarijn S. Tellman, Richard Dirven, Annemiek J. Linn, Gyorgy B. Halmos, Rob J.J.H. van Son, Lisette van der Molen, Alfons J.M. Balm, Julia C.M. van Weert, et al.


  • Open Access

    Decisional Conflict in Patients with Advanced Laryngeal Carcinoma: A Multicenter Study

    by Anne N. Heirman, Daan P. de Kort, Japke F. Petersen, Abrahim Al‐Mamgani, Simone E.J. Eerenstein, Bertram J. de Kleijn, Frank Hoebers, Bernard M. Tijink, Martijn M. Stuiver, Lisette van der Molen, et al.

    Objectives: Decision‐making for patients with a locally advanced laryngeal carcinoma (T3 and T4) is challenging due to the treatment choice between organ preservation and laryngectomy, both with different and high impact on function and quality of life (QoL). The complexity of these treatment decisions and their possible consequences might lead to decisional conflict (DC). This study aimed to explore the level of DC in locally advanced laryngeal carcinoma patients facing curative decision‐making, and to identify possible associated factors.Methods: In this multicenter prospective cohort study, participants completed questionnaires on DC, level of shared decision‐making (SDM), and a knowledge test directly after counseling and 6 months after treatment. Descriptive statistics and Spearman correlation tests were used to analyze the data.Results: Directly after counseling, almost all participants (44/45; 98%) experienced Clinically Significant DC score (CSDC >25, scale 0–100). On average, patients scored 47% (SD 20%) correct on the knowledge test. Questions related to radiotherapy were answered best (69%, SD 29%), whilst only 35% (SD 29%) of the questions related to laryngectomy were answered correctly. Patients' perceived level of SDM (scale 0–100) was 70 (mean, SD 16.2), and for physicians this was 70 (SD 1.7).Conclusion: Most patients with advanced larynx cancer experience high levels of DC. Low knowledge levels regarding treatment aspects indicate a need for better patient counseling.Level of Evidence: 4 Laryngoscope, 134:3604–3610, 2024


  • Open Access

    The development of a decision aid for patients with operable oropharyngeal carcinoma in the Netherlands – A mixed methods study

    by Anne N. Heirman, Richard Dirven, Lisette van der Molen, Willem H. Schreuder, Frank Hoebers, Jimmie Honings, Abrahim Al-Mamgani, Remco de Bree, Simone E.J. Eerenstein, Gyorgy B. Halmos, et al.


  • Open Access

    The acceptance and voice quality of a new voice prosthesis ‘Vega High performance’ – a feasibility study

    by Anne N. Heirman, Roosmarijn Sophie Tellman, Lisette van der Molen, Rob van Son, Klaske van Sluis, Gyorgy Bela Halmos, Michiel Wilhemus Maria Van Den Brekel, Richard Dirven

    Background: The Provox Vega High Performance (PVHP) is a newly developed voice prosthesis (VP) with an aim to achieve a longer and more predictable lifetime. Objectives: This feasibility study aims to assess patient acceptance of the PVHP VP, evaluate adverse events, voice quality, and device lifetime. Methods: Laryngectomized patients previously using a Provox Vega or ActiValve Light were included. Acceptance and voice outcomes were evaluated at two-time points with a 2-week interval. Baseline measurements were taken with the standard VP, followed by placement of the PVHP for the 2-week assessment. Results: Fifteen participants completed the study, with thirteen being initial Vega-users. PVHP acceptance was 87% 2 weeks after placement. Median device lifetime for all VPs was 64 d (range 14-370). In the subgroup without periprosthetic leakage, the median device lifetime was 101 d (range 31-370). Acceptance dropped to 40% after device failure. Voice quality did not differ between PVHP and baseline VP. The most reported adverse event was PVHP valve stickiness (46%). Conclusion and significance: Acceptance of the PVHP is largely dependent on device lifetime, decreasing from 87% to 40% after leakage or replacement. Voice quality remains consistent across different VPs. Developing a long-lasting VP remains a challenge.


  • Open Access

    Maximal cardiopulmonary exercise testing in laryngectomised patients using different heat and moisture exchangers – feasibility and exercise responses

    by Anne N. Heirman, Wim G. Groen, Lisette van der Molen, Richard Dirven, Michiel W.M. van Den Brekel, Martijn M Stuiver

    Objective: After laryngectomy, the breathing resistance of heat and moisture exchangers may limit exercise capacity. Breathing gas analysis during cardiopulmonary exercise testing is not possible using regular masks. This study tested the feasibility of cardiopulmonary exercise testing with a heat and moisture exchanger in situ, using an in-house designed connector. Additionally, we explored the effect of different heat and moisture exchanger resistances on exercise capacity in this group.Methods: Ten participants underwent two cardiopulmonary exercise tests using their daily life heat and moisture exchanger (0.3 hPa or 0.6 hPa) and one specifically developed for activity (0.15 hPa). Heat and moisture exchanger order was randomised and blinded.Results: All participants completed both tests. No (serious) adverse events occurred. Only four subjects reached a respiratory exchange ratio of more than 1.1 in at least one test. Maximum exercise levels using heat and moisture exchangers with different resistances did not differ.Conclusion: Cardiopulmonary exercise testing in laryngectomees with a heat and moisture exchanger is feasible; however, the protocol does not seem appropriate to reach this group's maximal exercise capacity. Lowering heat and moisture exchanger resistance does not increase exercise capacity in this sample.